- Filed
- Sep 29, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Sep 27, 2021 | 1.43B sh |
| Capex | Q3 2021 · Mar 31, 2021 | $0 |
| Capex restated | Q3 2021 · Mar 31, 2020 | $5.38K |
| Current Liabilities | Q3 2021 · Mar 31, 2021 | $4.38M |
| Current Liabilities | Q3 2021 · Jun 30, 2020 | $4.25M |
| Total Liabilities | Q3 2021 · Mar 31, 2021 | $4.38M |
| Total Liabilities | Q3 2021 · Jun 30, 2020 | $4.25M |
| Current Assets | Q3 2021 · Mar 31, 2021 | $33.46K |
| Current Assets | Q3 2021 · Jun 30, 2020 | $31.81K |
| Total Assets | Q3 2021 · Mar 31, 2021 | $57.83K |
| Total Assets | Q3 2021 · Jun 30, 2020 | $60.01K |
| Gross Profit | Q3 2021 · Mar 31, 2021 | $0 |
| Gross Profit | Q3 2021 · Mar 31, 2020 | −$32 |
| Gross Profit | Q3 2021 · Mar 31, 2020 | −$1.06K |
| Operating Cash Flow | Q3 2021 · Mar 31, 2020 | −$140.75K |
| Cash And Equivalents | Q3 2021 · Mar 31, 2020 | $2.63K |
| Cash And Equivalents | Q3 2021 · Jun 30, 2019 | $22.22K |
| Stockholders Equity | Q3 2021 · Mar 31, 2020 | −$3.75M |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | −$3.67M |
| Stockholders Equity | Q3 2021 · Sep 30, 2019 | −$3.38M |
| Stockholders Equity | Q3 2021 · Jun 30, 2019 | −$3.12M |
| Net Income | Q3 2021 · Mar 31, 2020 | −$235.94K |
| Net Income | Q3 2021 · Mar 31, 2020 | −$867.66K |
| Net Income | Q3 2021 · Dec 31, 2019 | −$296.54K |
| Net Income | Q3 2021 · Sep 30, 2019 | −$335.18K |
| Operating Income | Q3 2021 · Mar 31, 2020 | −$183.31K |
| Operating Income | Q3 2021 · Mar 31, 2020 | −$709.5K |
| Cost Of Revenue | Q3 2021 · Mar 31, 2020 | $6.11K |
| Revenue | Q3 2021 · Mar 31, 2020 | $0 |
| Revenue | Q3 2021 · Mar 31, 2020 | $5.04K |